GB Patent

GB0130341D0 — Compounds

Assigned to SmithKline Beecham Ltd · Expires 2002-02-06 · 24y expired

What this patent protects

This invention relates to heterocyclic substituted ethylene diamine derivatives and their use as pharmaceuticals.

USPTO Abstract

This invention relates to heterocyclic substituted ethylene diamine derivatives and their use as pharmaceuticals.

Drugs covered by this patent

Patent Metadata

Patent number: GB0130341D0
Jurisdiction: GB
Classification: —
Expires: 2002-02-06
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.